methyl (1S,4R,5S,5aS,9aR)-5-((2S)-2-hydroxy-2-(2-hydroxy-5-oxo-2,5-dihydrofuran-3-yl)ethyl)-5,9a-dimethyl-3-oxo-1,3,4,5,5a,6,7,9a-octahydro-1,4-methanobenzo[c]oxepine-9-carboxylate

Catalog No. :
ACRCYW325
CAS No. :
2244777-12-4
Molecular Formula :
C21H26O8
Molecular Weight :
406.43

IUPAC Name:methyl (1S,4R,5S,5aS,9aR)-5-((2S)-2-hydroxy-2-(2-hydroxy-5-oxo-2,5-dihydrofuran-3-yl)ethyl)-5,9a-dimethyl-3-oxo-1,3,4,5,5a,6,7,9a-octahydro-1,4-methanobenzo[c]oxepine-9-carboxylate

methyl (1S,4R,5S,5aS,9aR)-5-((2S)-2-hydroxy-2-(2-hydroxy-5-oxo-2,5-dihydrofuran-3-yl)ethyl)-5,9a-dimethyl-3-oxo-1,3,4,5,5a,6,7,9a-octahydro-1,4-methanobenzo[c]oxepine-9-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namemethyl (1S,4R,5S,5aS,9aR)-5-((2S)-2-hydroxy-2-(2-hydroxy-5-oxo-2,5-dihydrofuran-3-yl)ethyl)-5,9a-dimethyl-3-oxo-1,3,4,5,5a,6,7,9a-octahydro-1,4-methanobenzo[c]oxepine-9-carboxylate
IUPAC Namemethyl (1S,4R,5S,5aS,9aR)-5-((2S)-2-hydroxy-2-(2-hydroxy-5-oxo-2,5-dihydrofuran-3-yl)ethyl)-5,9a-dimethyl-3-oxo-1,3,4,5,5a,6,7,9a-octahydro-1,4-methanobenzo[c]oxepine-9-carboxylate
Molecular FormulaC21H26O8
Molecular Weight406.43
SMILESCOC(=O)C1=CCC[C@H]2[C@](C)(C[C@H](O)C3=CC(=O)OC3O)[C@H]3C[C@H](OC3=O)[C@@]12C
InChI KeyIWQROARLUZNGTO-VUSLHQQSSA-N
SynonymTinosporol A
CAS No.2244777-12-4

Synthetic Route by SureRoute

1. ACRCYW325 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRCYW325 route product structure diagram
    ACRCYW3252244777-12-4
Inquiry

2. ACRCYW325 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRCYW325 route product structure diagram
    ACRCYW3252244777-12-4
Inquiry

Comments (0)